RxDoctor Payments DataLook up a doctor →

Tosymra Sumatriptan Nasal Spray: payments to doctors

Payments that named Tosymra Sumatriptan Nasal Spray as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$252K
Providers
3,271
Transactions
9,473
Average per transaction
$27

The per-transaction average — $27 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,271 providers the average total is $77, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Upsher-smith Laboratories LLC$251,851100.0%
← All drugs & devices